SUNPHARMA.NS - Sun Pharmaceutical Industries Limited

NSE - NSE Real Time Price. Currency in INR

Sun Pharmaceutical Industries Limited

Sun House
CTS No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai 400063
India
91 22 4324 4324
http://www.sunpharma.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees30,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Dilip Shantilal ShanghviMD & Exec. Director31.8MN/A1955
Mr. Sailesh T. DesaiWhole Time Director13.9MN/A1954
Mr. Sudhir Vrundavandas ValiaWhole Time Director31.58MN/A1956
Mr. Kalyanasundaram SubramanianCEO of India Bus. & Emerging Markets and Exec. Non-Independent DirectorN/AN/A1954
Mr. Sunil R. AjmeraCompany Sec.11.75MN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, such as psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental, and nutritionals. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. The company has a collaboration agreement with International Centre for Genetic Engineering and Biotechnology to develop Dengue vaccine. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.

Corporate Governance

Sun Pharmaceutical Industries Limited’s ISS Governance QualityScore as of April 1, 2018 is 5. The pillar scores are Audit: 6; Board: 6; Shareholder Rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.